FGF23 stands out as a pivotal factor in the context of CKD, demonstrating its significance by being the earliest measurable MBD factor to increase, surpassing alterations in phosphate or PTH levels (Isakova et al., 2011). The gene discussed is PTH; the disease is Marchiafava-Bignami disease.